Jinan Jinda Pharmaceutical Chemistry Receives FDA Warning Letter
Jinan Jinda Pharmaceutical Chemi has not fixed GMP deficiencies at its Shandong plant say Spanish regulators calling for ban on nitrofurantoin shipments to the EU.
Jinan Jinda Pharmaceutical Chemistry Company's recent EDQM inspection resulted in a suspension of their certificate of suitability RO-CEP 2011-240-Rev 01/ Nitrofurantoin. Since then, Jinda has contracted ChemWerth to provide regulatory and compliance expertise to resolve the issues they are now facing.
Jinan Jinda Pharmaceutical Chemistry Co., Ltd. on FDA Import Alert List
FDA actions taken against Indian drugmakers have grabbed a lot of attention in recent years, but Europe has also been pushing foreign suppliers to hit higher standards. Each country does its own inspections but then shares any issues it finds through a common website. Most recently, Italy flagged problems with three plants, two in China and one in India.
Jinan Jinda Pharmaceutical Chemistry Fails EDQM Inspection